| Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET) (NCT01528241) | Novartis Pharmaceuticals | 2008-08-01 |
| Carac & PDT Combination in the Treatment Of Actinic Keratoses (NCT06712381) | Skin Laser & Surgery Specialists | 2008-08-01 |
| Plasma Levels of MK0633 in Children Ages 6-12 (0633-023) (NCT00751413) | Merck Sharp & Dohme LLC | 2008-08-01 |
| AZD5672 Absolute Bioavailability Study (NCT00746837) | AstraZeneca | 2008-08-01 |
| Safety Study Using Transcranial MR Guided Focused Ultrasound in the Treatment of Neuropathic Pain (NCT01699477) | University Children's Hospital, Zurich | 2008-08-01 |
| A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies (NCT00719836) | S*BIO | 2008-08-01 |
| Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours (NCT00750425) | AstraZeneca | 2008-08-01 |
| Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors (NCT00582816) | University of Wisconsin, Madison | 2008-08-01 |
| Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL (NCT00603668) | Gilead Sciences | 2008-08-01 |
| Rifampin Drug-Drug Interaction Study With Lurasidone HCl (NCT01082276) | Sumitomo Pharma America, Inc. | 2008-08-01 |
| Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions (NCT01621750) | Dr. Reddy's Laboratories Limited | 2008-08-01 |
| A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors (NCT00728793) | Curis, Inc. | 2008-08-01 |
| A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas (NCT00734682) | University of California, San Francisco | 2008-08-01 |
| Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage (NCT00850187) | Royan Institute | 2008-08-01 |
| AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01) (NCT00638612) | Candel Therapeutics, Inc. | 2008-08-01 |
| GSK1349572 Drug Interaction With Tenofovir (NCT00726336) | GlaxoSmithKline | 2008-08-01 |
| A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma (NCT00415155) | Eli Lilly and Company | 2008-08-01 |
| A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device (NCT00730977) | Syntara | 2008-08-01 |
| Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy (NCT01031953) | OHSU Knight Cancer Institute | 2008-08-01 |
| Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer (NCT00555672) | Pfizer | 2008-08-01 |
| Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia (NCT00718159) | Eli Lilly and Company | 2008-08-01 |
| Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531 (NCT00726115) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-08-01 |
| Phase I Trial of an Investigational Small Pox Medication (NCT00728689) | SIGA Technologies | 2008-08-01 |
| Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections (NCT00769613) | Milton S. Hershey Medical Center | 2008-08-01 |
| Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes (NCT00481117) | Eli Lilly and Company | 2008-08-01 |
| Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma (NCT00742963) | ImmunoGenesis | 2008-08-01 |
| Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma (NCT00651443) | Biogen | 2008-08-01 |
| Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain (NCT00685295) | Massachusetts General Hospital | 2008-08-01 |
| Phase I Study of U3P1287/01, Including Patients With Advanced Solid Tumors (NCT00730470) | U3 Pharma GmbH | 2008-08-01 |
| An Interaction Study With Digoxin and AZD1305 (NCT00712465) | AstraZeneca | 2008-08-01 |
| Efficacy and Safety of VA106483 in Elderly Males (NCT00879138) | Vantia Ltd | 2008-08-01 |
| Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio) (NCT00724594) | Medical University of South Carolina | 2008-08-01 |
| Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT00707590) | Bristol-Myers Squibb | 2008-08-01 |
| A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies (NCT00741403) | Cornerstone Pharmaceuticals | 2008-08-01 |
| Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors (NCT00747253) | Monteris Medical | 2008-08-01 |
| A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV (NCT00731471) | University of Oxford | 2008-08-01 |
| A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) (NCT00753415) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg (NCT00705367) | Bristol-Myers Squibb | 2008-08-01 |
| TMC278-TiDP6-C152: A Study to Assess the Effects of TMC278 and Efavirenz (EFV) on the QT/QTc Interval (Heart Conduction and Heart Rhythm) in Healthy Volunteers. (NCT00744809) | Tibotec Pharmaceuticals, Ireland | 2008-08-01 |
| Normothermic Ex Vivo Lung Perfusion (EVLP) For An Improved Assessment of Donor Lungs For Transplantation (NCT01190059) | XVIVO Perfusion | 2008-08-01 |
| Safety and Efficacy of Sildenafil in Cystic Fibrosis (CF) Lung Disease (NCT00659529) | National Jewish Health | 2008-08-01 |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions (NCT01344369) | Teva Pharmaceuticals USA | 2008-08-01 |
| Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 Years (NCT00783653) | Universitätsklinikum Hamburg-Eppendorf | 2008-08-01 |
| Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Type 1 Diabetics (NCT00752180) | Wockhardt | 2008-08-01 |
| Drug Discrimination in Methadone-Maintained Humans Study 2 (NCT00733239) | University of Arkansas | 2008-08-01 |
| Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment (NCT00828932) | Eisai Inc. | 2008-08-01 |
| Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36 (NCT00822705) | University Hospital, Basel, Switzerland | 2008-08-01 |
| A Safety/Tolerability and Pharmakokinetic Study of Sargramostim Administrated in the Gingiva (NCT00689143) | Innoventus Project AB | 2008-08-01 |
| Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED) (NCT00703261) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease (NCT00739037) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-08-01 |
| Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers (NCT00742820) | Fresenius Medical Care North America | 2008-08-01 |
| Substance Use Prevention in Teen Psychiatric Patients (NCT01170013) | Brown University | 2008-08-01 |
| Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton (NCT00748046) | Bayer | 2008-08-01 |
| A Single Dose Study Investigating the Elimination as Well as the Tolerability of PD 0332334 in Healthy Subjects as Compared to Patients With Impaired Kidney Function. (NCT00721422) | Pfizer | 2008-08-01 |
| Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. (NCT01073839) | University of Zurich | 2008-08-01 |
| Study of 9cUAB30 in Healthy Participants (NCT00896974) | National Cancer Institute (NCI) | 2008-08-01 |
| Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers (NCT02171559) | Boehringer Ingelheim | 2008-08-01 |
| IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (NCT00739609) | NewLink Genetics Corporation | 2008-08-01 |
| Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH) (NCT00795288) | Washington University School of Medicine | 2008-08-01 |
| Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00735930) | National Cancer Institute (NCI) | 2008-08-01 |
| Natural Killer Cells and Bortezomib to Treat Cancer (NCT00720785) | National Heart, Lung, and Blood Institute (NHLBI) | 2008-08-01 |
| A Study to Evaluate Safety, Tolerability and P-Glucose After Multiple Ascending Oral Doses of AZD1656 in Type 2 Diabetes (NCT00747175) | AstraZeneca | 2008-08-01 |
| A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies (NCT00732992) | Pfizer | 2008-08-01 |
| Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) (NCT00593944) | Bristol-Myers Squibb | 2008-08-01 |
| A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED) (NCT00758680) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma (NCT00683670) | University of Pennsylvania | 2008-08-01 |
| Safety Study of Erythropoietin (EPO) in Parkinson's Disease (NCT01010802) | International Center for Neurological Restoration, Cuba | 2008-08-01 |
| Buprenorphine Naltrexone-P1 A-Cocaine (NCT00733720) | National Institute on Drug Abuse (NIDA) | 2008-08-01 |
| Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP) (NCT00739505) | Alexion Pharmaceuticals, Inc. | 2008-08-01 |
| Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) (NCT00771472) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Non-Invasive Imaging of [18F]HX4 With Positron-Emission-Tomography (PET) (NCT00690053) | Maastricht Radiation Oncology | 2008-08-01 |
| Multiple Ascending Doses (MAD) of AZD3199 Given Once Daily as Inhaled Formulation Via Turbuhaler to Healthy Men (NCT00713271) | AstraZeneca | 2008-08-01 |
| A Study of PF-04217903 in Patients With Advanced Cancer (NCT00706355) | Pfizer | 2008-08-01 |
| Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Capsules Relative to That From Co-administration of ABT-335 and Rosuvastatin for the 5/45mg Dosage Form. (NCT00728780) | AstraZeneca | 2008-08-01 |
| A Pharmacokinetic and Relative Bioavailability Study With Rabeprazole Sodium in Healthy Adult Volunteers (NCT01101646) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2008-08-01 |
| Open-Label Disulfiram for Methamphetamine Dependence (NCT00731133) | University of Arkansas | 2008-08-01 |
| Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 Genotypes (NCT01704638) | Karolinska Institutet | 2008-08-01 |
| Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions (NCT02322645) | Dr. Reddy's Laboratories Limited | 2008-08-01 |
| Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918 (NCT00733031) | AstraZeneca | 2008-08-01 |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma (NCT00742924) | Children's Oncology Group | 2008-08-01 |
| Pilot Study of Oligonol Supplementation to Promote Cardiovascular Health (NCT01162174) | University of California, Davis | 2008-08-01 |
| Pharmacokinetics and Safety of Intravenous Topiramate in Adult Patients (NCT00753493) | University of Minnesota | 2008-08-01 |
| Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566. (NCT00749333) | AstraZeneca | 2008-08-01 |
| Single and Multiple Ascending Doses of AZD1981 in Japan (NCT00698282) | AstraZeneca | 2008-08-01 |
| Resveratrol in Healthy Adult Participants (NCT00721877) | National Cancer Institute (NCI) | 2008-08-01 |
| Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers (NCT00753870) | University of North Carolina, Chapel Hill | 2008-08-01 |
| The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT) (NCT00768066) | University of Miami | 2008-08-01 |
| Robotic Seed Implantation for Prostate Cancer Brachytherapy (NCT01341288) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-07-29 |
| Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma (NCT00687622) | GlaxoSmithKline | 2008-07-28 |
| GSK372475 PK Study in Healthy Volunteers (NCT00728208) | GlaxoSmithKline | 2008-07-28 |
| GSK706769/KALETRA Drug-drug Interaction Study (NCT00723775) | GlaxoSmithKline | 2008-07-24 |
| A Study To Assess The Effect Of SB-705498 In A Capsaicin Challenge Model (NCT00731250) | GlaxoSmithKline | 2008-07-22 |
| A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) (NCT00730275) | Merck Sharp & Dohme LLC | 2008-07-18 |
| Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of BIA 5-453 (NCT03099226) | Bial - Portela C S.A. | 2008-07-15 |
| Bioavailability Study of BIA 5-453 (NCT03090568) | Bial - Portela C S.A. | 2008-07-15 |
| Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults. (NCT00714285) | GlaxoSmithKline | 2008-07-14 |
| Study of MLN8237 in Participants With Advanced Hematological Malignancies (NCT00697346) | Millennium Pharmaceuticals, Inc. | 2008-07-11 |
| Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C (NCT00718172) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-07-11 |
| Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo (NCT01607086) | GlaxoSmithKline | 2008-07-11 |
| Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas (NCT00727233) | National Cancer Institute (NCI) | 2008-07-08 |